Photo by nci from unsplash
In high-risk patients treated with transcatheter aortic valve replacement (TAVR), half of all deaths after treatment are due to non-cardiac causes. Comorbid disease burden can be a major determinant of… Click to show full abstract
In high-risk patients treated with transcatheter aortic valve replacement (TAVR), half of all deaths after treatment are due to non-cardiac causes. Comorbid disease burden can be a major determinant of outcomes after TAVR. We sought to assess the relationship of comorbid disease burden at the time
Keywords:
comorbidity burden;
aortic valve;
valve replacement;
transcatheter aortic
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!